Amanote Research
Register
Sign In
532. Donor T Cells Specific for Multiple Leukemia Antigens for Adoptive Immunotherapy of Myeloid Leukemias After Stem Cell Transplantation
Molecular Therapy
- United States
doi 10.1016/s1525-0016(16)36336-5
Full Text
Open PDF
Abstract
Available in
full text
Categories
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Date
May 1, 2012
Authors
Unknown
Publisher
Elsevier BV
Related search
Low-Dose ARAC, Donor Cells, and GM-CSF for Treatment of Recurrent Acute Myeloid Leukemia After Allogeneic Stem Cell Transplantation
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Stem Cell Transplantation for Chronic Myeloid Leukemia in Children
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Failed Adoptive Immunotherapy With Tumor-Specific T Cells
Cancer Research
Cancer Research
Oncology
Antigen-Specific Culture of Memory-Like CD8 T Cells for Adoptive Immunotherapy
Cancer immunology research
Cancer Research
Immunology
Extramedullary Relapse of Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Acute Myeloid Leukemia Stem Cells and CD33-targeted Immunotherapy
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Donor-Cell Leukemia With Novel Genetic Features 2 Years After Sex-Mismatched T Cell-Depleted Haploidentical Stem Cell Transplantation
Annals of Hematology
Medicine
Hematology
ErbB2/HER2-specific NK Cells for Adoptive Cancer Immunotherapy
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Development of Adult T-Cell Leukemia in Donor-Derived Human T-Cell Leukemia Virus Type I-Infected T Cells After Allogeneic Bone Marrow Transplantation
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
